Skip to content
PoliTrackerPrototype - alpha version 0.1
← Policies

Proposed

Bill · 119th Congress · S 4220

Veterans Health Administration Novel Therapeutics Preparedness Act

Refreshed 3 h ago

Introduced 2026-03-26Topic: veterans military · health care · public health

Summary

AI-generated summary, report an error

This bill would create an Office of Novel Therapeutics within the Veterans Health Administration to set national policy, clinical standards, and training rules for new treatments under review by the Food and Drug Administration, such as certain psychedelic-assisted therapies for mental health conditions. The Office would plan how VA facilities could offer these treatments if approved, including staffing, space, and safety monitoring. The bill would set up a program to test these treatments in VA care, allow the VA to name centers of excellence, and create a veteran advisory committee. The VA would have to coordinate with other federal agencies, report to Congress every year, and submit a national preparedness strategy within 180 days.

Full text and official record on Congress.gov

Sponsors

Action history

DateChamberActionStatus effect
2026-04-29SenateCommittee on Veterans' Affairs. Hearings held.refer
2026-03-26SenateRead twice and referred to the Committee on Veterans' Affairs.refer
2026-03-26Introduced in Senateintroduce
Source: GovInfo Bill Status (Library of Congress), fetched 2026-09-11. Provisions and opinion polling arrive in a later release.